These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5576944)

  • 1. [Desipramine in the therapy of Parkinson's disease].
    De Divitiis E; Signorelli CD; Cerillo A
    Rass Int Clin Ter; 1971 Feb; 51(4):222-6. PubMed ID: 5576944
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between desipramine plasma levels and the effect in Parkinson's syndrome.
    Muscettola GB; Giovannucci M; Montanini R; Morselli PL; Garattini S
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):375-9. PubMed ID: 5079227
    [No Abstract]   [Full Text] [Related]  

  • 3. Desipramine in treatment of Parkinson's disease. A placebo-controlled study.
    Laitinen L
    Acta Neurol Scand; 1969; 45(1):109-13. PubMed ID: 4896078
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
    Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 7. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Parkinson's disease with ciladopa.
    Aminoff MJ; Goodin DS; Habermann-Little B; Cutler JR
    Ann Neurol; 1987 Mar; 21(3):311. PubMed ID: 3606037
    [No Abstract]   [Full Text] [Related]  

  • 11. Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
    Lieberman AN; Gopinathan G; Neophytides A; Hiesiger E; Nelson J; Walker R; Goodgold A
    N Y State J Med; 1984 Jan; 84(1):13-6. PubMed ID: 6422358
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR
    Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of disipal in Parkinson's disease].
    Zheng JH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):199-200. PubMed ID: 4075907
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bromocriptine in Parkinson's disease. Personal experience].
    Chacón JR; Piqueras L; Pery JM
    Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinsonian syndromes with two derivates of iminodibenzil: imipramine (tofranil) and desipramine (pertrofana)].
    De La Herrán Matorra
    Rev Clin Esp; 1967 Sep; 106(5):390-4. PubMed ID: 5597129
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of initial pharmacotherapy for Parkinson's disease in the United States.
    Huse DM; Castelli-Haley J; Orsini LS; Lenhart G; Abdalla JA
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):91-7. PubMed ID: 16690994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of L-deprenyl in Parkinson's disease].
    Zhonghua Yi Xue Za Zhi; 1983 Mar; 63(3):147-9. PubMed ID: 6409375
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome].
    Avenarius HJ; Gerstenbrand F
    Wien Klin Wochenschr; 1968 Jun; 80(23):460-2. PubMed ID: 5704572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mental disorders in patients with Parkinson's disease treated with L-dopa].
    Piccirilli M; Piccinin GL
    Clin Ter; 1981 Jun; 97(5):473-9. PubMed ID: 7273659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.